Who owns EVOMMUNE INC?
- Ticker: EVMN
- CUSIP Number: 30054y107
Tip: Access positions for across all investors
Analyze quarterly positions in Evommune with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Evommune stock
Who bought or sold EVOMMUNE INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| EQT Fund Management S.a r.l. | 4.9M | $84M | 100% | Dec 2025 |
|
| RA Capital Management | 3.5M | $59M | 100% | Dec 2025 |
|
| Pivotal bioVenture Partners Investment Advisor | 1.9M | $33M | 100% | Dec 2025 |
|
| Nan Fung Group Holdings | 1.4M | $25M | 100% | Dec 2025 |
|
| Rtw Investments | 1.3M | $22M | 100% | Dec 2025 |
|
| Marshall Wace | 988k | $17M | 100% | Dec 2025 |
|
| Eventide Asset Management | 962k | $17M | 100% | Dec 2025 |
|
| Sectoral Asset Management | 589k | $10M | 100% | Dec 2025 |
|
| Verition Fund Management | 565k | $9.7M | 100% | Dec 2025 |
|
| Standard Life Aberdeen | 525k | $9.0M | 100% | Dec 2025 |
|
| Velan Capital Investment Management | 507k | $8.7M | 100% | Dec 2025 |
|
| Vanguard Group | 503k | $8.6M | 100% | Dec 2025 |
|
| Octagon Capital Advisors | 500k | $8.6M | 100% | Dec 2025 |
|
| American Century Companies | 418k | $7.1M | 100% | Dec 2025 |
|
| Federated Investors | 325k | $5.6M | 100% | Dec 2025 |
|
| Dr. Jeffrey R. Jay, M.D. | 325k | $5.6M | 100% | Dec 2025 |
|
| Kynam Capital Management | 186k | $3.2M | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 184k | $3.2M | 100% | Dec 2025 |
|
| Monashee Investment Management | 183k | $3.1M | 100% | Dec 2025 |
|
| Sphera Funds Management | 166k | $2.8M | 100% | Dec 2025 |
|
| Sofinnova Ventures | 153k | $2.6M | 100% | Dec 2025 |
|
| BlackRock | 142k | $2.4M | 100% | Dec 2025 |
|
| Integral Health Asset Management | 125k | $2.1M | 100% | Dec 2025 |
|
| MPM Oncology Impact Management | 113k | $1.9M | 100% | Dec 2025 |
|
| Geode Capital Management | 110k | $1.9M | 100% | Dec 2025 |
|
| Ameriprise Financial | 105k | $1.8M | 100% | Dec 2025 |
|
| Seven Grand Managers | 75k | $1.3M | 100% | Dec 2025 |
|
| Stempoint Capital | 68k | $1.2M | 100% | Dec 2025 |
|
| Balyasny Asset Management | 65k | $1.1M | 100% | Dec 2025 |
|
| Charles Schwab Investment Management | 63k | $1.1M | 100% | Dec 2025 |
|
| Goldman Sachs Group | 62k | $1.1M | 100% | Dec 2025 |
|
| Capricorn Fund Managers | 60k | $1.0M | 100% | Dec 2025 |
|
| Citadel Advisors | 51k | $866k | 100% | Dec 2025 |
|
| Burkehill Global Management | 50k | $856k | 100% | Dec 2025 |
|
| TD Asset Management | 45k | $764k | 100% | Dec 2025 |
|
| Point72 Asset Management | 34k | $589k | 100% | Dec 2025 |
|
| Tudor Investment Corporation | 32k | $547k | 100% | Dec 2025 |
|
| State Street Corporation | 32k | $539k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 24k | $412k | 100% | Dec 2025 |
|
| Northern Trust | 23k | $388k | 100% | Dec 2025 |
|
| Two Sigma Investments | 21k | $365k | 100% | Dec 2025 |
|
| Oxford Asset Management | 20k | $335k | 100% | Dec 2025 |
|
| XTX Topco | 19k | $322k | 100% | Dec 2025 |
|
| Manufacturers Life Insurance Company | 10k | $179k | 100% | Dec 2025 |
|
| UBS Group | 3.4k | $58k | 100% | Dec 2025 |
|
| Tower Research Capital | 2.7k | $47k | 100% | Dec 2025 |
|
| National Bank Of Canada /fi/ | 2.2k | $38k | 100% | Dec 2025 |
|
| China Universal Asset Management | 2.0k | $34k | 100% | Dec 2025 |
|
| Legal & General Group | 400.00 | $6.8k | 100% | Dec 2025 |
|
| Brian McDonald | 20.00 | $293.334000 | 100% | Dec 2025 |
|